Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Sep 30, 2021 8:11pm
117 Views
Post# 33950477

RE:RE:RE:RE:MedX to Present at Benzinga Healthcare Conference on Septemb

RE:RE:RE:RE:MedX to Present at Benzinga Healthcare Conference on Septemb

They stated that they were going to be doing a lot of pilots and they would tell the market how long the pilots would run and what the potential would be once the pilot was finished and they converted the pilot to a commercial contract. 

If you read their last press release. https://stockhouse.com/news/press-releases/2021/09/27/medx-health-corp-and-vitamed-biomedical-s-r-l-to-pilot-leading-edge

T
hey have languaged the release differently. The pilot will run for 60 days then they will start a rollout. Mike said in the presentation that the pilot is not to evaluate the technology that is already done before the pilot. The pilot merely looks at the patients response and makes any adjustments necessary to make the project more successful. 

If you follow the logic you will be able to measure the pilots get a sense of the conversion ratio and figure out the install levels. I suspect they wouldn't have given that guidance unless they know they have a number of pilots in the hopper that are coming to fruition. 

That is what I took away from the presentation and if that is the case your comments will be addressed. 

<< Previous
Bullboard Posts
Next >>